Heska Corporation Second Quarter 2019 Financial Results and Earnings Call Scheduled for August 6, 2019

Heska Corporation Second Quarter 2019 Financial Results and Earnings Call Scheduled for August 6, 2019

PR Newswire

LOVELAND, Colo., July 16, 2019 /PRNewswire/ -- Heska Corporation (NASDAQ: HSKA - News; "Heska" or the "Company"), a provider of advanced veterinary diagnostic and specialty products, plans to report its second quarter 2019 financial performance in a press release on Tuesday, August 6, 2019 before the market opens and to host an earnings call to discuss the results at 9 a.m. MT / 11 a.m. ET on the same day.

Heska Corporation (PRNewsfoto/Heska Corporation)

To access the conference call:

From within the United States, please dial 1-800-289-0438
From outside of the United States, please dial 1-323-794-2423
Reference Conference ID: 7297179

The earnings call will be webcast live from the Company's website at https://ir.heska.com/event/heska-second-quarter-2019-earnings-call-webcast/.

A telephonic replay will be available beginning at 2 p.m. ET August 6 and will continue through 11:59 p.m. ET on Tuesday, August 20, 2019. The webcast will be archived on www.heska.com for 90 days.

To access the replay:

From within the United States, please dial 1-844-512-2921
From outside the United States, please dial 1-412-317-6671
Reference Replay Pin Number: 7297179

About Heska
Heska Corporation (NASDAQ: HSKA - News) manufactures, develops and sells advanced veterinary diagnostic and specialty healthcare products through two business segments; Core Companion Animal Health ("CCA") represents approximately 80% of revenues, and Other Vaccines and Pharmaceuticals ("OVP") segment represents approximately 20% of revenues. CCA segment includes Point of Care Laboratory testing instruments and consumables, primarily under a unique multi-year Reset Subscription model, digital imaging products, software and services, local and cloud-based data services, allergy testing and immunotherapy, and single use offerings such as in-clinic diagnostic tests and heartworm preventive products. OVP segment includes private label vaccine and pharmaceutical production under third-party agreements and channels, primarily for herd animal health. For additional information on Heska and its products, visit www.heska.com.

 

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/heska-corporation-second-quarter-2019-financial-results-and-earnings-call-scheduled-for-august-6-2019-300885152.html

SOURCE Heska Corporation

Copyright CNW Group 2019